Tideglusib for the Treatment of Amyotrophic Lateral Sclerosis

NCT05105958 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
98
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Zurich

Collaborators